| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ENOV | Common stock, par value $.001 | +Options Exercise | $1,977,000 | +50,000 | +16.36% | $39.54 | 355,708 | Oct 15, 2021 | Direct | |
| transaction | ENOV | Common stock, par value $.001 | -Sell | -$1,882,604 | -37,199 | -10.46% | $50.61 | 318,509 | Oct 15, 2021 | Direct | F1, F2 |
| transaction | ENOV | Common stock, par value $.001 | -Sell | -$651,289 | -12,801 | -4.02% | $50.88 | 305,708 | Oct 15, 2021 | Direct | F1, F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ENOV | Employee Stock Option (right to buy) | -Options Exercise | $0 | -50,000 | -9.28% | $0.00 | 488,600 | Oct 15, 2021 | Common stock, par value $.001 | 50,000 | $39.54 | Direct | F4 |
| Id | Content |
|---|---|
| F1 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. |
| F2 | The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.78 to $50.77, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4. |
| F3 | The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.78 to $51.04, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4. |
| F4 | The option vests in equal installments on the third, fourth and fifth anniversaries of the grant date, which was 7/24/2015. |